Published in J R Soc Interface on September 08, 2010
Concise review: cell therapies: the route to widespread adoption. Stem Cells Transl Med (2012) 0.88
Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine. Stem Cells Int (2012) 0.80
Stem cell-based bone repair. Am J Stem Cells (2012) 0.78
Adipose Tissue - Adequate, Accessible Regenerative Material. Int J Stem Cells (2015) 0.76
Translation and commercialization of regenerative medicines. J R Soc Interface (2010) 0.75
Breaking gridlock in health policy?; Comment on "A new synthesis". Int J Health Policy Manag (2014) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
Tissue engineering. Science (1993) 19.65
Clinical transplantation of a tissue-engineered airway. Lancet (2008) 10.04
Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature (2009) 8.70
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet (2006) 7.64
Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A (2010) 7.31
Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature (2010) 7.05
Third-generation biomedical materials. Science (2002) 3.89
Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol (1974) 3.75
Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells (2010) 3.48
Hematopoietic-cell transplantation at 50. N Engl J Med (2007) 2.98
Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun (2000) 2.28
Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: implications and applications for bone tissue engineering. Calcif Tissue Int (2000) 1.68
Stem cells in the umbilical cord. Stem Cell Rev (2006) 1.63
HAEMATOPOIETIC CHIMERA IN MAN AFTER ALLOGENIC (HOMOLOGOUS) BONE-MARROW TRANSPLANTATION. (CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE DUE TO THE CHIMERISM). Br Med J (1963) 1.59
Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation. Nat Mater (2009) 1.42
Transplantation of kidneys, experimentally and in human cases. Am J Surg (1954) 1.36
Successful clinical implementation of corneal epithelial stem cell therapy for treatment of unilateral limbal stem cell deficiency. Stem Cells (2010) 1.21
Stem cell bioprocessing: fundamentals and principles. J R Soc Interface (2009) 1.17
The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials (2008) 1.12
Chondrogenic differentiation of human mesenchymal stem cells on oriented nanofibrous scaffolds: engineering the superficial zone of articular cartilage. Tissue Eng Part A (2009) 1.09
Stem cell differentiation and expansion for clinical applications of tissue engineering. J Cell Mol Med (2007) 0.96
Breaking ground on translational stem cell research. Ann N Y Acad Sci (2010) 0.78
A safer stem cell: inducing pluripotency. Nat Med (2009) 0.77